What was the market valuation of the India kidney stones market in 2024?

The market valuation of the India kidney stones market was $118.8 Million in 2024. Read More

What is the projected market valuation for the India kidney stones market by 2035?

The projected market valuation for the India kidney stones market is $205.0 Million by 2035. Read More

What is the expected CAGR for the India kidney stones market during the forecast period 2025 - 2035?

The expected CAGR for the India kidney stones market during the forecast period 2025 - 2035 is 5.08%. Read More

Which type of kidney stones had the highest valuation in 2024?

In 2024, Calcium Oxalate Stones had the highest valuation, ranging from $40.0 Million to $70.0 Million. Read More

What are the key treatment types in the India kidney stones market?

Key treatment types include Medications, Ureteroscopy, Extracorporeal Shock Wave Lithotripsy, and Percutaneous Nephrolithotomy. Read More

What was the valuation range for Ureteroscopy in 2024?

The valuation range for Ureteroscopy in 2024 was between $35.0 Million and $60.0 Million. Read More

Which diagnostic method had the highest valuation in 2024?

In 2024, the diagnostic method 'Others' had the highest valuation, ranging from $43.8 Million to $80.0 Million. Read More

Who are the key players in the India kidney stones market?

Key players in the market include Boston Scientific, Medtronic, Johnson & Johnson, and C.R. Bard. Read More

What was the valuation range for Struvite Kidney Stones in 2024?

The valuation range for Struvite Kidney Stones in 2024 was between $15.0 Million and $30.0 Million. Read More

What is the projected growth trend for the India kidney stones market?

The India kidney stones market is expected to grow steadily, reaching a valuation of $205.0 Million by 2035. Read More

India Kidney Stones Market

ID: MRFR/HC/51106-HCR 200 Pages Nidhi Mandole Last Updated: September 17, 2026

India Kidney Stones Market Research Report: By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy) andBy Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others) - Growth & Industry Forecast 2025 To 2035

India Kidney Stones Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.08%

2024 Market Size$ 118.8 Million

2025 Market Size$ 124.84 Million

2035 Market Size$ 205 Million

Key Players

Boston Scientific

Medtronic

Johnson & Johnson

C.R. Bard

Cook Medical

Stryker

Trends

Rising Incidence of Kidney Stones
Technological Advancements in Treatment
Increased Awareness and Preventive Measures

Opportunities

Rising Healthcare Expenditure
Increase in Geriatric Population
Advancements in Medical Technology

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Type (USD Million)
  1. 4.1.1 Calcium Oxalate Stones
  2. 4.1.2 Uric Acid
  3. 4.1.3 Struvite Kidney Stones
  4. 4.1.4 Cystine Stones
  5. 4.1.5 Calcium Phosphate Stones
2. 4.2 Healthcare, BY Treatment Type (USD Million)
  1. 4.2.1 Medications
  2. 4.2.2 Extracorporeal Shock Wave Lithotripsy
  3. 4.2.3 Ureteroscopy
  4. 4.2.4 Percutaneous Nephrolithotomy
3. 4.3 Healthcare, BY Diagnosis (USD Million)
  1. 4.3.1 Ultrasound
  2. 4.3.2 Intravenous Pyelography
  3. 4.3.3 CT Scan
  4. 4.3.4 X-Ray
  5. 4.3.5 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Boston Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 C.R. Bard (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cook Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Stryker (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Olympus Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Karl Storz (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Fujifilm Holdings Corporation (JP)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY TYPE
3. 6.3 INDIA MARKET ANALYSIS BY TREATMENT TYPE
4. 6.4 INDIA MARKET ANALYSIS BY DIAGNOSIS
5. 6.5 KEY BUYING CRITERIA OF HEALTHCARE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF HEALTHCARE
8. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
11. 6.11 HEALTHCARE, BY TYPE, 2024 (% SHARE)
12. 6.12 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 HEALTHCARE, BY TREATMENT TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY DIAGNOSIS, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY DIAGNOSIS, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Enquiry

Customize Report

India India Kidney Stones Market Segmentation

India Kidney Stones Market By Type (USD Million, 2025-2035)

Calcium Oxalate Stones
Uric Acid
Struvite Kidney Stones
Cystine Stones
Calcium Phosphate Stones

India Kidney Stones Market By Treatment Type (USD Million, 2025-2035)

Medications
Extracorporeal Shock Wave Lithotripsy
Ureteroscopy
Percutaneous Nephrolithotomy

India Kidney Stones Market By Diagnosis (USD Million, 2025-2035)

Ultrasound
Intravenous Pyelography
CT Scan
X-Ray
Others

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”